Sangamo Therapeutics Inc (SGMO) Stock Price & News

HomeSGMO • NASDAQ

Sangamo Therapeutics Inc

$0.38

Jan 21, 3:14:18 PM GMT-5 · USD · NASDAQ · Disclaimer

StockUS listed securityUS headquartered

Previous close

$0.37

Day range

$0.37 - $0.40

Year range

$0.37 - $1.40

Market cap

126.69M USD

Avg Volume

4.22M

P/E ratio

Dividend yield

Primary exchange

NASDAQ

Market news

CNBC

1 hour ago

The S&P 500 and 10-year yield pain levels that could cause Trump to rethink Greenland push

Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process

Dow surges 700 points after Trump announces Greenland framework, calls off tariff threat

Stock market today: Dow, S&P 500, Nasdaq futures slip after brutal sell-off in wait for Trump's Davos speech

Investor's Business Daily

2 hours ago

Stock Market Today: Dow Rises On Trump Pledge; Nvidia CEO Flags AI Investment Growth (Live Coverage)

Axios

10 hours ago

Trump 2.0 stock market underperforms Trump 1.0

About

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases. Wikipedia

CEO

Sandy Macrae

Founded

1995

Headquarters

Richmond, California
United States

Website

sangamo.com

Employees

183